Articles published by Robbins LLP
Stockholder Notice: Robbins LLP Informs Stockholders of the BioAge Labs, Inc. Class Action
January 08, 2025
From Robbins LLP
Via GlobeNewswire
Tickers
BIOA
Stockholder Notice: Robbins LLP Informs Stockholders of the Regeneron Pharmaceuticals, Inc. Class Action Lawsuit
January 08, 2025
From Robbins LLP
Via GlobeNewswire
Tickers
REGN
APLT Investor Alert: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Applied Therapeutics, Inc.
January 06, 2025
From Robbins LLP
Via GlobeNewswire
Tickers
APLT
CPRI Investor Alert: Robbins LLP Reminds Stockholders of the Capri Holdings Limited Class Action
January 02, 2025
From Robbins LLP
Via GlobeNewswire
Tickers
CPRI
Stockholder Notice: Robbins LLP Informs Stockholders of Caribou Biosciences, Inc. of the Class Action Lawsuit
January 02, 2025
From Robbins LLP
Via GlobeNewswire
Tickers
CRBU
RIG Investor Alert: Robbins LLP Reminds Stockholders of the Transocean Ltd. Class Action
January 02, 2025
From Robbins LLP
Via GlobeNewswire
Tickers
RIG
NXT Investor Alert: Robbins LLP Reminds Stockholders of the Nextracker Inc. Class Action
January 02, 2025
From Robbins LLP
Via GlobeNewswire
Tickers
NXT
HUMA Lead Plaintiff Deadline Approaching – Contact Robbins LLP for Information About the Class Action Against Humacyte, Inc.
December 24, 2024
From Robbins LLP
Via GlobeNewswire
Tickers
HUMA
MGP Ingredients, Inc. Investor Alert: Robbins LLP Reminds Stockholders of the MGPI Class Action Lawsuit
December 23, 2024
From Robbins LLP
Via GlobeNewswire
Tickers
MGPI
APLT Investor Alert: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Applied Therapeutics, Inc.
December 23, 2024
From Robbins LLP
Via GlobeNewswire
Tickers
APLT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.